Sanofi US News

Each employee will be able to share in the movement of solidarity by choosing either to make financial donation to the projects of the villages “twinned,” or partnered, with his or her site and country, or to sponsor a child by joining an aid charity as a private member.

The twinning projects have been selected in close consultation with sanofi-aventis teams and managers in the stricken countries, who have visited the devastated areas in order to find out what is most needed and to meet with partner aid agencies.

The associations involved in the various partnerships are:

• Père Ceyrac Association,
• Solidarités,
• Isha Foundation,
• SEEDS (Sustainable Environment and Ecological Development Society)
• UNICEF in Indonesia
• Handicap International,
• Croix Rouge Thaïlandaise (Thaï Red Cross Society)
• Sarvodaya,
• Sewalanka.  

The associations involved in the children sponsorship are:

• SOS Villages d’Enfants
• Enfants du Mékong.  

Sanofi-aventis will donate 500,000 euros to launch these projects. This amount will be added to employee donations.

The day after the disaster, sanofi-aventis acted to meet and satisfy urgently the needs. Group affiliates in stricken countries mobilized to provide emergency medical supplies to NGOs and groups in the field, under coordination of the government of each affected country.

On January 2, Jean-François Dehecq, Chairman and CEO of sanofi-aventis, accompanied Philippe Douste-Blazy, France’s Minister for Health, Solidarity and the Family, on his mission to Sri Lanka, transporting six tons of medicines donated by sanofi-aventis: antibiotics, anti-diarrhea and antibacterial medicines.

In addition, sanofi-aventis shipped out to the Indonesian government, via UNICEF, 600 000 anti-measle vaccines and 150 000 anti-paludism doses. 

An initial donation of 300,000 euros was made to the French Red Cross on December 30.

A donation of 100,000 euros was made on January 4, to the Association du Père Ceyrac, a charity working in Tamil Nadu in Southern India.

Another donation will be made to the sanofi-aventis Group association 
“Nos enfants, c’est essentiel” to help employees affected by the disaster in these countries.

About sanofi-aventis
Sanofi-aventis is the world’s 3rd largest pharmaceutical company, ranking number 1 in Europe.  Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, vaccines. Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).